Back to Agenda
Session 5: Interactive Activity: How could CMC Lifecycle Management change in the future?
Session Chair(s)
Ben Thompson
Vice President, CMC and Non-clinical Regulatory Affairs
GlaxoSmithKline, United Kingdom
Frank Montgomery, PhD
Global Head Regulatory CMC, GRAPSQA
AstraZeneca, United Kingdom
Susanne Ausborn, PhD
Global Head International Regulatory Policy
Roche, Switzerland
Sylvie Meillerais, MSc
Director Global CMC Policy
MSD Belgium, Belgium
Sara Torgal, MPharm
Senior Manager, Scientific Programs
DIA, Switzerland
Have an account?